Variant | Gene | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||
---|---|---|---|---|---|---|---|---|---|---|
|
0.100 | GeneticVariation | BEFREE | A gain-of-function polymorphism in human neuropeptide Y (<i>NPY</i>) gene (rs16139) associates with metabolic disorders and earlier onset of type 2 diabetes (T2D). | 28468933 | 2017 |
||||
|
0.100 | GeneticVariation | BEFREE | The present study attempts to investigate the association of NPY exon2 +1128 T/C (Leu7Pro; rs16139), NPY promoter -399 T/C (rs16147) and IL1B -511 C/T (rs16944) polymorphisms with TIID and their correlation with plasma lipid levels, BMI, and IL1B transcript levels. | 27749914 | 2016 |
||||
|
0.100 | GeneticVariation | BEFREE | We investigated the associations of inflammatory blood cell activation with vascular parameters in patients with type 2 diabetes to elucidate the possible mechanisms of accelerated atherosclerosis observed in subjects with the Leucine 7 to Proline 7 polymorphism (Leu7Pro) in the neuropeptide Y (NPY). | 21746772 | 2011 |
||||
|
0.100 | GeneticVariation | BEFREE | The Leu7Pro polymorphism of the signal peptide of neuropeptide Y (NPY) gene is associated with increased levels of inflammatory markers preceding vascular complications in patients with type 2 diabetes. | 20691708 | 2010 |
||||
|
0.100 | GeneticVariation | BEFREE | The leucine7 to proline7 (Leu7Pro) polymorphism in preproneuropeptide Y (preproNPY) has been associated with accelerated atherosclerosis and type II diabetes, both of which are obesity-related diseases. | 18043699 | 2009 |
||||
|
0.100 | GeneticVariation | BEFREE | Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects. | 17268419 | 2007 |
||||
|
0.100 | GeneticVariation | BEFREE | Since no impact of preproNPY genotype on mean NPY or hormone levels were detected in subjects with type 2 diabetes, the mechanisms for the increased risk for diabetic complications in the subjects with the Leu7Pro polymorphism need to be further explored. | 17516289 | 2007 |
||||
|
0.100 | GeneticVariation | BEFREE | These results suggest that the Leu7Pro polymorphism could be used to predict earlier onset of type 2 diabetes and retinopathy, and increased risk for diabetic nephropathy. | 16705546 | 2006 |
||||
|
0.100 | GeneticVariation | BEFREE | The present study thus provides the evidence that Leu7Pro polymorphism in the NPY gene is associated with IGT and T2DM in Swedish men, and indicates that the NPY gene variations contribute to development of T2DM. | 15926114 | 2005 |
||||
|
0.100 | GeneticVariation | BEFREE | Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects. | 10852461 | 2000 |
||||
|
0.100 | GeneticVariation | BEFREE | Leucine 7 to proline 7 polymorphism in the neuropeptide y gene is associated with retinopathy in type 2 diabetes. | 10926322 | 2000 |